Citations

Showing 10 of 108094 citations.

Hyperbaric oxygen as a treatment modality in cyclophosphamide‐induced hemorrhagic cystitis
Kaur, Dominder , Khan, Shakila P. , Rodriguez, Vilmarie , Arndt, Carola, Claus, Paul

Mayo Clinic

Pediatric Transplantation | March 23, 2018 | Volume: 22 | Issue: 4 | Pages: No page available

10.1111/petr.13171 | PMID 29569791 Get It

AbstractLate‐onset HC is a well‐recognized complication associated with cyclophosphamide/acrolein‐induced toxicity. It poses a management challenge when hyperhydration and bladder irrigation do not result in clinical improvement as desired. The data regarding use of hyperbaric oxygen therapy (HBO2) as an early treatment modality in this clinical setting are limited. We present 2 cases, that were refractory to hyperhydration and bladder irrigation but responded to HBO2. They were treated with 20‐30 daily sessions over weekdays with 100% oxygen for 90 minutes at 2 atmospheric pressure units (2 atm). Both patients reported improved symptoms within the first 15 sessions, and hematuria diminished by 20 sessions. Hyperbaric oxygen is a less invasive, outpatient therapy that is effective for treatment of HC and is tolerated well by young patients.
Ossabaw Pigs With a PCSK9 Gain‐of‐Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies
Yuan, Fang , Guo, Liang , Park, Kyoung‐Ha , Woollard, John R. , Kwon, Taek‐Geun , Melkamu, Tamene, Zang, Bin , Fahrenkrug, Scott C. , Kolodgie, Frank D. , Lerman, Lilach O. , Carlson, Daniel F. , Jiang, Kai , Jiang, Kai , Smith, Samantha Louise , Lerman, Amir , Virmani, Renu

Mayo Clinic

Journal of the American Heart Association | March 23, 2018 | Volume: 7 | Issue: 6 | Pages: No page available

10.1161/jaha.117.006207 | PMID 29572319 Get It

Background Ossabaw pigs are unique miniature swine with genetic predisposition to develop metabolic syndrome and coronary atherosclerosis after extended periods receiving atherogenic diets. We have hypothesized that transgenic Ossabaw swine expressing chimp PCSK9 (proprotein convertase subtilisin‐like/kexin type 9) containing the D374Y gain of function would develop familial hypercholesterolemia and coronary artery plaques more rapidly than Landrace swine with the same transgene. Methods and Results Ossabaw and Landrace PCSK9 gain‐of‐function founders were generated by Sleeping Beauty transposition and cloning. Histopathologic findings in the Ossabaw founder animal showed more advanced plaques and higher stenosis than in the Landrace founder, underscoring the Ossabaw genetic predisposition to atherosclerosis. We chose to further characterize the Ossabaw PCSK9 gain‐of‐function animals receiving standard or atherogenic diets in a 6‐month longitudinal study using computed tomography, magnetic resonance (MR) imaging, intravascular ultrasound, and optical coherence tomography, followed by pathological analysis of atherosclerosis focused on the coronary arteries. The Ossabaw model was consistently hypercholesterolemic, with or without dietary challenge, and by 6 months had consistent and diffuse fibrofatty or fibroatheromatous plaques with necrosis, overlying fibrous caps, and calcification in up to 10% of coronary plaques. Conclusions The Ossabaw PCSK9 gain‐of‐function model provides consistent and robust disease development in a time frame that is practical for use in preclinical therapeutic evaluation to drive innovation. Although no animal model perfectly mimics the human condition, this genetic large‐animal model is a novel tool for testing therapeutic interventions in the context of developing and advanced coronary artery disease.
Textured Breast Implants: A Closer Look at the Surface Debris Under the Microscope
Webb, Leland H., Aime, Victoria , Do, Annie, Mossman, Kenneth L., Mahabir, Raman C. , Aime, Victoria L

Mayo Clinic

Plastic Surgery | March 23, 2018 | Volume: 25 | Issue: 3 | Pages: 179-183

10.1177/2292550317716127 | PMID 29026824 Get It

Background: Texturing of breast implants is done to decrease the risk of associated complications. Each manufacturer utilizes unique and at times proprietary techniques to texture the surface of their implants. Little is known about the integrity of this surface structure texturing or the propensity for the surfaces to shed particulate matter. This study aimed to determine the extent of surface particulate shedding from 3 textured implants approved by the US Food and Drug Administration (FDA), which are manufactured by Allergan, Mentor, and Sientra. Methods: Control images of each of the 3 textured breast implants were obtained with scanning electron microscopy (SEM). A liquid adhesive, ethylene vinyl acetate (EVA) copolymer was then applied to the external shell of the implants, allowed to cool, and peeled from the surface. Images of the EVA copolymer were taken with SEM to qualitatively analyze displacement of surface particulate debris. Scanning electron microscopy imaging of the implants was repeated for qualitative comparisons with the control images. Results: The peeled copolymer of the 3 implants exhibited surface shedding. Comparison of the 3 breast implants showed the shedding to be greatest for the Allergan implant. Conclusions: This study highlights the dynamic surface material properties of the 3 FDA-approved breast implants. Shedding of particulate matter from the implant surfaces can be precipitated by moderate adhesion. Our qualitative examination of SEM findings showed more debris shed from the Allergan breast implants than from the Mentor or Sientra implants.
Splenic Rupture as the First Manifestation of Babesia Microti Infection: Report of a Case and Review of Literature
Dumic, Igor , Patel, Janki, Hart, Melissa, Niendorf, Eric, Martin, Scott, Ramanan, Poornima , Niendorf, Eric R, Dumic, Igor

Mayo Clinic

American Journal of Case Reports | March 23, 2018 | Volume: 19 | Issue: No issue available | Pages: 335-341

10.12659/ajcr.908453 | PMID 29567936 Get It

Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience
Dholaria, Bhagirathbhai , Hammond, William A. , Sher, Taimur , Vishnu, Prakash , Soyano, Aixa , Finn, Laura , Dholaria, Bhagirathbhai R , Vishnu, Prakash , Soyano, Aixa , Tun, Han, Roy, Vivek , Tun, Han W.

Mayo Clinic

Leukemia & Lymphoma | March 23, 2018 | Volume: 59 | Issue: 11 | Pages: 2727-2730

10.1080/10428194.2018.1452220 | PMID 29566563 Get It

Predicting Long-Term Global Outcome after Traumatic Brain Injury: Development of a Practical Prognostic Tool Using the Traumatic Brain Injury Model Systems National Database
Stromberg, Katharine, Marwitz, Jennifer H. , Šíma, Adam , Agyemang, Amma A. , Graham, Kristin M. , Harrison‐Felix, Cynthia , Hoffman, Jeanne M. , Kreutzer, Jeffrey S., Merchant, Randall E., Brown, Allen W. , Walker, William C. , Kreutzer, Jeffrey S.

Mayo Clinic

Journal of Neurotrauma | March 23, 2018 | Volume: 35 | Issue: 14 | Pages: 1587-1595

10.1089/neu.2017.5359 | PMID 29566600 Get It

Response to Commercial Genetic Testing and the Future of the Genetic Counseling Profession
Goodenberger, McKinsey L. , Thomas, Brittany C. , Kruisselbrink, Teresa , Goodenberger, McKinsey

Mayo Clinic

Journal of Genetic Counseling | March 23, 2018 | Volume: 27 | Issue: 3 | Pages: 530-532

10.1007/s10897-018-0253-5 | PMID 29569053 Get It

First Year Medical Student Peer Nominations of Professionalism: A Methodological Detective Story about Making Sense of Non‐Sense
Mullikin, Trey C. , Shahi, Varun, Grbic, Douglas , Pawlina, Wojciech, Hafferty, Frederic W.

Mayo Clinic

Anatomical Sciences Education | March 22, 2018 | Volume: 12 | Issue: 1 | Pages: 20-31

10.1002/ase.1782 | PMID 29569347 Get It

This article explores the assessment of professionalism within a cohort of medical students during a sequential 13‐week medical school histology and anatomy course. Across seven data points, students were asked to identify a professionalism role model from amongst their peers and to score Likert‐structured rationales for their decision. Based on density scores, an initial social network analysis identified six peer‐nomination “stars.” However, analysis of these stars revealed considerable variability and random‐like “noise” in both the nomination and explanation data sets. Subsequent analyses of both data sets explored the possibility of underlying patterns in this noise using tests of reliability, principal components factor analysis, and fixed‐effects regression analysis. These explorations revealed the presence of two dimensions (professional vs. supportive) in how students sought to explain their nomination decisions. Although data variability remained quite high, significantly less variability was present in the professional than in the supportive dimension, suggesting that academic helpfulness rationales are both empirically distinct and more mutable than rationales grounded in professionalism‐related factors. In addition, data showed that the greater the stability in one's choice of a professionalism role model nomination over the T1–T7 data periods, the more stable one's reasons for that nomination—both for professionalism and supportive dimensions. Results indicate that while peer assessment of professionalism by first‐year medical students may not be very reliable, students can differentiate between more personal and professional factors, even at this early stage in their professional development. Formal instruction within the pre‐clinical curriculum should recognize and address this distinction. Anat Sci Educ. © 2018 American Association of Anatomists.
Tobacco Dependence Treatment Grants: A Collaborative Approach to the Implementation of WHO Tobacco Control Initiatives
Nolan, Margaret , Kemper, Katherine E. , Glynn, Thomas J. , Hurt, R. Douglas , Nolan, Margaret B , Hays, J. Taylor

Mayo Clinic

Journal of Environmental and Public Health | March 22, 2018 | Volume: 2018 | Issue: No issue available | Pages: 1-9

10.1155/2018/8429738 | PMID 29765430 Get It

The number of global tobacco-related deaths is projected to increase from about 6 million to 8 million annually by 2030, with more than 80% of these occurring in low- and middle-income countries (LMICs). The World Health Organization Framework Convention on Tobacco Control (FCTC) came into force in 2005 and Article 14 relates specifically to the treatment of tobacco dependence. However, LMICs, in particular, face several barriers to implementing tobacco dependence treatment. This paper is a descriptive evaluation of a novel grant funding mechanism that was initiated in 2014 to address these barriers. Global Bridges. Healthcare Alliance for Tobacco Dependence Treatment aims to create and mobilize a global network of healthcare professionals and organizations dedicated to advancing evidence-based tobacco dependence treatment and advocating for effective tobacco control policy. A 2014 request for proposals (RFP) focused on these goals, particularly in LMICs, where funding for this work had been previously unavailable. 19 grants were awarded by Global Bridges to organizations in low- and middle-income countries across all six WHO regions. Virtually all focused on developing a tobacco dependence treatment curriculum for healthcare providers, while also influencing the political environment for Article 14 implementation. As a direct result of these projects, close to 9,000 healthcare providers have been trained in tobacco dependence treatment and an estimated 150,000 patients have been offered treatment. Because most of these projects are designed with a “train-the-trainer” component, two years of grant funding has been a tremendous catalyst for accelerating change in tobacco dependence treatment practices throughout the world. In order to foster such exponential growth and continue to maintain the impact of these projects, ongoing financial, educational, and professional commitments are required.
Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology
Vidal, Claudia I. , Armbrect, Eric A., Andea, Aleodor A. , Bohlke, Angela, Comfere, Nneka I. , Hughes, Sarah , Kim, Jinah , Kozel, Jessica A. , Lee, Jason B. , Linos, Konstantinos , Litzner, Brandon R. , Missall, Tricia A. , Sundram, Uma , Swick, Brian L. , Hurley, M. Yadira , Alam, Murad , Argényi, Zsolt B., Duncan, Lyn M., Elston, Dirk M. , Emanuel, Patrick O. , Ferringer, Tammie , Fung, Maxwell A. , Hosler, Gregory A. , Lazar, Alexander J. , Prieto, Víctor G. , Schaffer, András , Subtil, Antonio , Wang, Wei‐Lien , Sundram, Uma , Hurley, Maria Yadira , Emanuel, Patrick O , Fung, Maxwell A , Hosler, Gregory A , Lazar, Alexander J , Vidal, Claudia I , Kim, Jinah , Linos, Konstantinos , Missall, Tricia A , Novoa, Roberto A. , Alam, Murad , Lowe, Lori , Plaza, Jose Antonio , Robinson, June K.

Mayo Clinic

Journal of Cutaneous Pathology | March 22, 2018 | Volume: 45 | Issue: 8 | Pages: 563-580

10.1111/cup.13142 | PMID 29566273 Get It

BackgroundAppropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy and physician decision‐making.ObjectivesThe American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology.MethodsThe RAND/UCLA appropriateness methodology, which combines evidence‐based medicine, clinical experience and expert judgment, was used to develop AUC in dermatopathology.ResultsWith the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered “usually appropriate,” 52 (25%) “rarely appropriate” and 43 (20%) “uncertain appropriateness.”LimitationsThe methodology requires a focus on appropriateness without comparison between tests and irrespective of cost.ConclusionsThe ultimate decision of when to order specific test rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness—AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed “uncertain appropriateness” and where consensus was not reached may benefit from further research.